Clinical Indication

Treatment of angiodysplasia in the background of von Willebrand's disease second line to thalidomide use.

Date of classification

March 2022


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.